Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 4/20 | 0.37 |
| ▸ | SELP | P16109 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | FUT4 | P22083 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17366364 | 0.78 | — | — | |
| SCHEMBL23784698 | 0.77 | ACHE (0.48) | ALDH1A1LMNAHSD17B10CA12CA1 | |
| SCHEMBL18292827 | 0.77 | ACHE (0.42) | KDM4ELMNAMAPTMAPK1BLM | |
| SCHEMBL12630762 | 0.76 | CA1 (0.56) | KDM4EALDH1A1LMNAMAPTTDP1 | |
| SCHEMBL24265817 | 0.76 | SERPINE1 (0.38) | SELLSELPKDM4EALDH1A1LMNA | |
| SCHEMBL24266012 | 0.73 | NPC1 (0.39) | SELLSELPHPGDMAPK1HTT | |
| SCHEMBL17506714 | 0.72 | ACHE (0.42) | KDM4EMAPTCASP6 | |
| SCHEMBL11046141 | 0.70 | KDM4E (0.42) | SELLSELPKDM4EALDH1A1LMNA | |
| SCHEMBL14233302 | 0.70 | MCL1 (0.39) | SELLSELPHSD17B10SELECYP2C9 | |
| SCHEMBL11408792 | 0.69 | CA1 (0.52) | SELLSELPKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-10 | — | — | US | disclosed |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-07-12 | — | — | US | disclosed |
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-05-19 | — | — | US | disclosed |
| US-20220054516-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | ACE, ACE2, FURIN | SELL 1484/4885SELP 558/4885KDM4E 4466/4885 |
| US-20220054516-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | ACE, ACE2, FURIN | SELL 1484/4885SELP 558/4885KDM4E 4466/4885 |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | ACE, ACE2, FURIN | SELL 1484/4885SELP 558/4885KDM4E 4466/4885 |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | ACE, ACE2, FURIN | SELL 1484/4885SELP 558/4885KDM4E 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.